Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes-Reference-Cited by-同舟云学术

Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes

Published:2008-11-19 Issue:2 Volume:49 Page:627-636
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Vick Binje,Weber Achim,Urbanik Toni,Maass Thorsten,Teufel Andreas,Krammer Peter H.,Opferman Joseph T.,Schuchmann Marcus,Galle Peter R.,Schulze-Bergkamen Henning

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.22664/fullpdf

Reference33 articles.

1. The Bcl-2 apoptotic switch in cancer development and therapy;Adams;Oncogene,2007

2. Death by association: BH3 domain-only proteins and liver injury;Baskin-Bey;Am J Physiol Gastrointest Liver Physiol,2005

3. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function;Chen;Mol Cell,2005

4. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly;Kuwana;Mol Cell,2005

5. Mcl-1 deficiency results in peri-implantation embryonic lethality;Rinkenberger;Genes Dev,2000

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax;Hemato;2024-08-27

2. Blockage of BCL-XL overcomes venetoclax resistance across BCL2+ lymphoid malignancies irrespective of BIM status;Blood Advances;2024-06-28

3. Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia;Leukemia;2024-04-10

4. Anti-apoptotic MCL-1 promotes long-chain fatty acid oxidation through interaction with ACSL1;Molecular Cell;2024-04

5. The mitochondrial genome-encoded peptide MOTS-c interacts with Bcl-2 to alleviate nonalcoholic steatohepatitis progression;Cell Reports;2024-01